ZEISS at AAO 2026

The American Academy of Ophthalmology annual meeting convenes in New Orleans, Louisiana, where ZEISS Medical Technology will present connected clinical workflows and digital infrastructure designed to standardize data transfer across cataract, refractive, retina, and glaucoma procedures.

Core Technology and System Architecture
The core of the presented architecture involves connected cataract workflow solutions and cloud-based software platforms that automate operational steps between preoperative diagnostics and surgical execution. ZEISS VERACITY Surgery Planner interfaces diagnostic instrumentation with electronic health record platforms to synthesize patient biometric data into immediate surgical plans. In the operating room, visualization is expanded through the HMDmd CR3, a head-mounted display interfacing with the ZEISS ARTEVO 850 surgical microscope. The system transmits digital overlays from AdVision, including real-time optical coherence tomography scans, cataract refractive assistant tracking, depth-of-field control, and digital color adjustment, directly into the operator view to support a neutral cervical spine posture during prolonged procedures. For corneal assessment, the ZEISS ATLAS 500 utilizes Placido-disk ring geometry calibrated across zero to four millimeter zones to capture and quantify anterior eye segment topography.

Deployment or Implementation
The software platforms operate on hybrid clinical infrastructures. Local diagnostic hubs connect to central archives via ZEISS FORUM, while the browser-based ZEISS CLINIC 360 platform provides cloud aggregation for clinical analytics. Front-end patient access systems, including ZEISS VisioGen, interface with the top ten practice management and electronic health records systems in the United States, utilizing optometrist review protocols to process patient routing into practice scheduling systems. In the operating room, surgical workflow integration extends to specialized pharmacology, where single-use prefilled syringes of DORC TissueBlue (Brilliant Blue G 0.025%) provide selective staining of the internal limiting membrane during vitreoretinal surgery, requiring complete intraocular evacuation post-staining to mitigate tissue complications.

Industry Applications
Targeted at surgical centers, outpatient clinics, and hospital ophthalmology departments, these integrated platforms address ergonomic strain, manual diagnostic transcription errors, and distributed patient data bottlenecks. Concrete technical use cases encompass keratorefractive lenticule extraction procedures using femtosecond laser platforms, visual field threshold testing using virtual reality perimetry headsets to complement stationary Humphrey Field Analyzers, and anterior segment disease monitoring. The resulting operational benefits include stabilized procedural efficiency, reduced physical operator fatigue, and consistent diagnostic repeatability.

Operational Impact and Performance Metrics
Deployment data demonstrates scale across automated clinical planning and operative procedures. ZEISS VERACITY Surgery Planner has processed over three million planned surgical cases, while keratorefractive lenticule extraction with ZEISS SMILE and ZEISS SMILE pro platforms has achieved fifteen million completed eyes across more than eighty countries. In clinical intake evaluations across three practice deployments, the VisioGen interface converted 1,397 website inquiries into 215 completed surgical interventions.

"The ZEISS ATLAS 500 requires minimal training through its on-screen prompts and guides, but still presents intricate data captured, quantified, and analyzed on the screen," says Dr. Joseph Nazarian, optometrist and founder of Nazarian Optometrists.

Edited by Evgeny Churilov, Induportals Media - Adapted by AI.

www.zeiss.com